NTL Healthcare says CerviCARE AI has been supplied to Zimbabwe

What happened

NTL Healthcare says it has supplied CerviCARE AI to Zimbabwe, according to a company announcement distributed through PR Newswire on 19 October. The release does not identify the Zimbabwean receiving facility, the deployment scale or the terms of the supply.

CerviCARE AI analyses cervical images to identify potential lesions. The company describes it as an AI-assisted screening system and says it can operate without an internet connection. These are company-stated details; the announcement does not include an independent assessment of its deployment in Zimbabwe.

Commercial perspective

The reported supply indicates market activity involving AI-assisted cervical screening in Zimbabwe. The source does not establish nationwide availability or a national rollout. Further local information would be needed to assess the scale of adoption, training arrangements and integration with existing screening services.

Attribution: PR Newswire, distributing an NTL Healthcare company announcement.